Cutting the cancer care paperwork mountain

CVS Health's Aetna is overhauling how it handles prior authorizations for cancer patients, bundling what was previously a string of separate approvals — covering chemotherapy, radiation, immunotherapy, and related imaging like MRIs and CT scans — into a single upfront request. The goal: less administrative drag for physicians and faster access to care for patients.

The streamlined process is already live for Medicaid members in eight states (Oklahoma, Illinois, Maryland, New Jersey, Virginia, Florida, Kentucky, and West Virginia), with a broader rollout to Medicare Advantage and commercial plan members slated for the first half of 2027.

By the numbers:

• On average, providers were submitting 4 separate prior authorizations per Aetna cancer patient per treatment course
• 74% of providers flagged administrative burden as a top clinical challenge; 31% specifically cited prior authorizations
• Insurers industry-wide have cut 11% of prior authorizations since pledging reform last year
• At least 1 in 8 standard prior auth requests in government programs were denied last year — most overturned on appeal

Why it matters: Prior authorization has long been a flashpoint between insurers and clinicians, contributing to provider burnout and treatment delays. Aetna's move — alongside UnitedHealthcare's pledge to cut 30% of its prior auth requirements — signals a broader industry shift, though many physicians remain skeptical that announcements will translate into meaningful relief.